These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22163165)

  • 21. Practically feasible production of sustained-release microspheres of granulocyte-macrophage colony-stimulating factor (rhGM-CSF).
    Wu F; Dai L; Geng L; Zhu H; Jin T
    J Control Release; 2017 Aug; 259():195-202. PubMed ID: 28389408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of interleukin-11 with and without granulocyte colony-stimulating factor on in vivo neonatal rat hematopoiesis: induction of neonatal thrombocytosis by interleukin-11 and synergistic enhancement of neutrophilia by interleukin-11 + granulocyte colony-stimulating factor.
    Cairo MS; Plunkett JM; Nguyen A; Schendel P; van de Ven C
    Pediatr Res; 1993 Jul; 34(1):56-61. PubMed ID: 7689197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutrophil activation and hemostatic changes in healthy donors receiving granulocyte colony-stimulating factor.
    Falanga A; Marchetti M; Evangelista V; Manarini S; Oldani E; Giovanelli S; Galbusera M; Cerletti C; Barbui T
    Blood; 1999 Apr; 93(8):2506-14. PubMed ID: 10194429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new concept in treatment of burn injury: controlled slow-release granulocyte-monocyte colony-stimulating factor chitosan gel system.
    Simsek S; Canter HI; Konas E; Korkusuz P; Demir D; Oner F; Unsal I; Mavili ME
    Ann Plast Surg; 2011 Dec; 67(6):583-8. PubMed ID: 22123539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Granulocyte Colony-Stimulating Factor Nanocarriers for Stimulation of the Immune System (Part I): Synthesis and Biodistribution Studies.
    De Crozals G; Kryza D; Sánchez GJ; Roux S; Mathé D; Taleb J; Dumontet C; Janier M; Chaix C
    Bioconjug Chem; 2018 Mar; 29(3):795-803. PubMed ID: 29283548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-derived granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor prolong the survival of neutrophils infiltrating bronchoalveolar subtype pulmonary adenocarcinoma.
    Wislez M; Fleury-Feith J; Rabbe N; Moreau J; Cesari D; Milleron B; Mayaud C; Antoine M; Soler P; Cadranel J
    Am J Pathol; 2001 Oct; 159(4):1423-33. PubMed ID: 11583970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells.
    Winter JN; Lazarus HM; Rademaker A; Villa M; Mangan C; Tallman M; Jahnke L; Gordon L; Newman S; Byrd K; Cooper BW; Horvath N; Crum E; Stadtmauer EA; Conklin E; Bauman A; Martin J; Goolsby C; Gerson SL; Bender J; O'Gorman M
    J Clin Oncol; 1996 Jan; 14(1):277-86. PubMed ID: 8558209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased respiratory burst activity of neutrophils in patients with aplastic anemia: effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.
    Ohsaka A; Kitagawa S; Yuo A; Motoyoshi K; Ohta M; Miura Y; Takaku F; Saito M
    Exp Hematol; 1992 Oct; 20(9):1090-3. PubMed ID: 1281785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic study of a novel recombinant human granulocyte colony-stimulating factor in rats.
    Liu XX; Jiang YP
    Chin Med Sci J; 2010 Mar; 25(1):13-9. PubMed ID: 20449948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intranasal absorption of granulocyte-colony stimulating factor (G-CSF) from powder formulations, in sheep.
    Gill IJ; Fisher AN; Farraj N; Pitt CG; Davis SS; Illum L
    Eur J Pharm Sci; 1998 Jan; 6(1):1-10. PubMed ID: 16256702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo pharmacokinetics and pharmacodynamics of positional isomers of mono-PEGylated recombinant human granulocyte colony stimulating factor in rats.
    Kang JS; Lee KC
    Biol Pharm Bull; 2013; 36(7):1146-51. PubMed ID: 23811564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic/pharmacodynamic analysis of neutrophil proliferation induced by recombinant granulocyte colony-stimulating factor (rhG-CSF): comparison between intravenous and subcutaneous administration.
    Sugiura M; Yamamoto K; Sawada Y; Iga T
    Biol Pharm Bull; 1997 Jun; 20(6):684-9. PubMed ID: 9212991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in the development of an acute neutrophil inflammatory response in mice.
    Metcalf D; Robb L; Dunn AR; Mifsud S; Di Rago L
    Blood; 1996 Nov; 88(10):3755-64. PubMed ID: 8916939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo effect of recombinant human granulocyte colony-stimulating factor on neutrophilic expression of CD11b in septic neonates: a randomized controlled trial.
    El-Ganzoury MM; El-Farrash RA; Saad AA; Mohamed AG; El-Sherbini IG
    Pediatr Hematol Oncol; 2012 Apr; 29(3):272-84. PubMed ID: 22475305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions of granulocyte-macrophage colony-stimulating factor (CSF), granulocyte CSF, and tumor necrosis factor alpha in the priming of the neutrophil respiratory burst.
    Khwaja A; Carver JE; Linch DC
    Blood; 1992 Feb; 79(3):745-53. PubMed ID: 1370644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Phase Ⅳ clinical trial for external use of recombinant human granulocyte-macrophage colony-stimulating factor gel in treating deep partial-thickness burn wounds].
    Liu J; Liao ZJ; Zhang Q
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):542-8. PubMed ID: 27647071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulation and in vitro-in vivo evaluation of black raspberry extract-loaded PLGA/PLA injectable millicylindrical implants for sustained delivery of chemopreventive anthocyanins.
    Desai KG; Olsen KF; Mallery SR; Stoner GD; Schwendeman SP
    Pharm Res; 2010 Apr; 27(4):628-43. PubMed ID: 20148292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Granulocyte colony-stimulating factor improves host defense to resuscitated shock and polymicrobial sepsis without provoking generalized neutrophil-mediated damage.
    Patton JH; Lyden SP; Ragsdale DN; Croce MA; Fabian TC; Proctor KG
    J Trauma; 1998 May; 44(5):750-8; discussion 758-9. PubMed ID: 9603074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Granulocyte-Colony Stimulating Factor Nanocarriers for Stimulation of the Immune System (Part II): Dose-Dependent Biodistribution and In Vivo Antitumor Efficacy in Combination with Rituximab.
    Kryza D; De Crozals G; Mathe D; Taleb Sidi-Boumedine J; Janier M; Chaix C; Dumontet C
    Bioconjug Chem; 2018 Mar; 29(3):804-812. PubMed ID: 29283559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of growth factors on doxorubicin-induced skin necrosis: documentation of histomorphological alterations and early treatment by GM-CSF and G-CSF.
    Vargel I; Erdem A; Ertoy D; Pinar A; Erk Y; Altundag MK; Gullu I
    Ann Plast Surg; 2002 Dec; 49(6):646-53. PubMed ID: 12461449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.